<DOC>
	<DOCNO>NCT02096172</DOCNO>
	<brief_summary>The objective study evaluate impact pharmacogenomic aspect drug metabolism measurement drug drug metabolites urine drug testing ( UDT ) .</brief_summary>
	<brief_title>Urine Toxicology With Pharmacogenomic Interpretation Assay : UTOPIA</brief_title>
	<detailed_description />
	<criteria>Able provide write informed consent Pharmacogenomic testing within last 60 day Planned UDT Subject chronic renal dysfunction , Chronic Kidney Disease Stage 4 5 Subject history abnormal hepatic function within last 2 year ( INR &gt; 1.2 attributable anticoagulant medication , AST ALT &gt; 1.5x normal , suspected cirrhosis ) Subject history malabsorption ( short gut syndrome ) ; Subject history gastric small bowel surgery ; Subject currently hospitalize ; Subject currently receive intravenous medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>